234 related articles for article (PubMed ID: 36517884)
1. Modelling Alzheimer's disease using human brain organoids: current progress and challenges.
Yanakiev M; Soper O; Berg DA; Kang E
Expert Rev Mol Med; 2022 Dec; 25():e3. PubMed ID: 36517884
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial vulnerability to oxidation in human brain organoids modelling Alzheimer's disease.
Holubiec MI; Alloatti M; Bianchelli J; Greloni F; Arnaiz C; Gonzalez Prinz M; Fernandez Bessone I; Pozo Devoto V; Falzone TL
Free Radic Biol Med; 2023 Nov; 208():394-401. PubMed ID: 37657763
[TBL] [Abstract][Full Text] [Related]
3. Modeling Alzheimer's Disease Using Human Brain Organoids.
Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S
Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268
[TBL] [Abstract][Full Text] [Related]
4. Pushing the boundaries of brain organoids to study Alzheimer's disease.
Cerneckis J; Bu G; Shi Y
Trends Mol Med; 2023 Aug; 29(8):659-672. PubMed ID: 37353408
[TBL] [Abstract][Full Text] [Related]
5. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
6. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
Raja WK; Mungenast AE; Lin YT; Ko T; Abdurrob F; Seo J; Tsai LH
PLoS One; 2016; 11(9):e0161969. PubMed ID: 27622770
[TBL] [Abstract][Full Text] [Related]
7. Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.
Bi FC; Yang XH; Cheng XY; Deng WB; Guo XL; Yang H; Wang Y; Li J; Yao Y
Transl Neurodegener; 2021 Aug; 10(1):27. PubMed ID: 34372927
[TBL] [Abstract][Full Text] [Related]
8. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure.
Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y
Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898
[TBL] [Abstract][Full Text] [Related]
9. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
10. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.
Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H
Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261
[TBL] [Abstract][Full Text] [Related]
11. Galangin Rescues Alzheimer's Amyloid-β Induced Mitophagy and Brain Organoid Growth Impairment.
Zhang R; Lu J; Pei G; Huang S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834819
[TBL] [Abstract][Full Text] [Related]
12. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
13. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
14. [Technical characteristics of Alzheimer model based on organ technology (organoid)].
Tzekaki E; Tsolaki M; Pantazaki A
Hell J Nucl Med; 2019; 22 Suppl():195-208. PubMed ID: 30877738
[TBL] [Abstract][Full Text] [Related]
15. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
Pavoni S; Jarray R; Nassor F; Guyot AC; Cottin S; Rontard J; Mikol J; Mabondzo A; Deslys JP; Yates F
PLoS One; 2018; 13(12):e0209150. PubMed ID: 30557391
[TBL] [Abstract][Full Text] [Related]
18. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
19. Research Progress in the Pathogenesis of Alzheimer's Disease.
Chen YG
Chin Med J (Engl); 2018 Jul; 131(13):1618-1624. PubMed ID: 29941717
[TBL] [Abstract][Full Text] [Related]
20. Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer's Disease.
Hernández D; Rooney LA; Daniszewski M; Gulluyan L; Liang HH; Cook AL; Hewitt AW; Pébay A
Stem Cell Rev Rep; 2022 Feb; 18(2):718-731. PubMed ID: 33725267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
